Skip to main content

Advertisement

SpringerLink
Log in

Coronary Artery Disease in Patients with Liver Cirrhosis

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background The prevalence of coronary artery disease (CAD) has been reported to be low in patients with liver cirrhosis. Previous studies have, however, included mostly patients with cirrhosis due to hepatitis C. We aimed to determine the prevalence and predictive factors of CAD in a cohort of consecutive patients with cirrhosis of various etiologies compared to the general population. Methods A total of 127 patients with cirrhosis were evaluated for a history of CAD and cardiovascular risk factors. Arterial blood pressure, fasting plasma glucose, and serum cholesterol were measured. Nutritional status was assessed by anthropometry and estimation of recent weight change. A group of 203 subjects from the general population with similar age and gender distribution, as well as smoking habits as the cirrhotic patients, served as controls. Results CAD was more common in cirrhotics compared to controls (20% vs. 12%, P = 0.001). Compared to controls, cirrhotics had lower mean arterial blood pressure and serum cholesterol and a higher prevalence of diabetes, but did not differ significantly in the prevalence of hypertension or family history for CAD. In regression analysis, CAD was independently related to diabetes (odds ratio [OR] 5.47, 95% confidence interval [CI] 2.44–12.28), but not to liver cirrhosis. In the cirrhosis group, only alcoholic cirrhosis (OR 9.50, 95% CI 1.08–83.4) and age (OR 1.23 per year, 95% CI 1.06–1.43) were independently related to CAD. Conclusions Liver cirrhosis, per se, does not seem to confer a protective effect against CAD. In cirrhotics, older age and alcoholic etiology were independently related to CAD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CAD:

Coronary artery disease

CI:

Confidence interval

ECG:

Electrocardiogram

HDL:

High-density lipoprotein

INR:

International normalized ratio

LDL:

Low-density lipoprotein

MELD:

Model for end-stage liver disease

BMI:

Body mass index

OR:

Odds ratio

SD:

Standard deviation

References

  1. Howell WL, Manion WC. The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: a review of 639 cases of cirrhosis of the liver from 17,731 autopsies. Am Heart J. 1960;60:341–344. doi: 10.1016/0002-8703(60)90192-7.

    Article  CAS  PubMed  Google Scholar 

  2. Kane WC, Aronson SM. Cerebrovascular disease in an autopsy population. 4. Reduced frequency of stroke in patients with liver cirrhosis. Trans Am Neurol Assoc. 1971;96:259–260.

    CAS  PubMed  Google Scholar 

  3. Melato M, Mucli E, Poldrugo F, et al. Stroke–cirrhosis relationship: an autopsy study in a heavy drinking population. Ital J Gastroenterol. 1991;23:211–214.

    CAS  PubMed  Google Scholar 

  4. Berzigotti A, Bonfiglioli A, Muscari A, et al. Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis. Liver Int. 2005;25:331–336. doi: 10.1111/j.1478-3231.2005.01002.x.

    Article  PubMed  Google Scholar 

  5. Carey WD, Dumot JA, Pimentel RR, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation. 1995;59:859–864. doi: 10.1097/00007890-199503270-00010.

    Article  CAS  PubMed  Google Scholar 

  6. Donovan CL, Marcovitz PA, Punch JD, et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation. 1996;61:1180–1188. doi: 10.1097/00007890-199604270-00011.

    Article  CAS  PubMed  Google Scholar 

  7. Plotkin JS, Benitez RM, Kuo PC, et al. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg. 1998;4:253–257. doi: 10.1002/lt.500040415.

    Article  CAS  PubMed  Google Scholar 

  8. Tiukinhoy-Laing SD, Rossi JS, Bayram M, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol. 2006;98:178–181. doi: 10.1016/j.amjcard.2006.01.089.

    Article  PubMed  Google Scholar 

  9. D’Arienzo A, Manguso F, Scaglione G, et al. Prognostic value of progressive decrease in serum cholesterol in predicting survival in Child-Pugh C viral cirrhosis. Scand J Gastroenterol. 1998;33:1213–1218. doi: 10.1080/00365529850172593.

    Article  PubMed  Google Scholar 

  10. Henriksen JH, Møller S. Hypertension and liver disease. Curr Hypertens Rep. 2004;6:453–461. doi: 10.1007/s11906-004-0041-5.

    Article  PubMed  Google Scholar 

  11. Nishida T, Tsuji S, Tsujii M, et al. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol. 2006;101:70–75. doi: 10.1111/j.1572-0241.2005.00307.x.

    Article  PubMed  Google Scholar 

  12. Marchesini G, Ronchi M, Forlani G, et al. Cardiovascular disease in cirrhosis—a point-prevalence study in relation to glucose tolerance. Am J Gastroenterol. 1999;94:655–662.

    CAS  PubMed  Google Scholar 

  13. Fujiwara F, Ishii M, Taneichi H, et al. Low incidence of vascular complications in patients with diabetes mellitus associated with liver cirrhosis as compared with type 2 diabetes mellitus. Tohoku J Exp Med. 2005;205:327–334. doi: 10.1620/tjem.205.327.

    Article  PubMed  Google Scholar 

  14. Merli M, Riggio O, Dally L. Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology. 1996;23:1041–1046. doi: 10.1002/hep.510230516.

    Article  CAS  PubMed  Google Scholar 

  15. Matos C, Porayko MK, Francisco-Ziller N, et al. Nutrition and chronic liver disease. J Clin Gastroenterol. 2002;35:391–397. doi: 10.1097/00004836-200211000-00007.

    Article  CAS  PubMed  Google Scholar 

  16. Campillo B, Richardet JP, Scherman E, et al. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition. 2003;19:515–521. doi: 10.1016/S0899-9007(02)01071-7.

    Article  PubMed  Google Scholar 

  17. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470. doi: 10.1053/jhep.2001.22172.

    Article  CAS  PubMed  Google Scholar 

  18. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–721. doi: 10.1053/jhep.2002.31250.

    Article  PubMed  Google Scholar 

  19. Symreng T. Arm anthropometry in a large reference population and in surgical patients. Clin Nutr. 1982;1:211–219. doi: 10.1016/0261-5614(82)90015-2.

    Article  CAS  PubMed  Google Scholar 

  20. Stratton RJ, Green CJ, Elia M. Disease-Related Malnutrition: An Evidence-Based Approach to Treatment. Oxon: CAB International; 2003.

    Google Scholar 

  21. Berg C, Rosengren A, Aires N, et al. Trends in overweight and obesity from 1985 to 2002 in Göteborg, West Sweden. Int J Obes Lond. 2005;29:916–924. doi: 10.1038/sj.ijo.0802964.

    Article  CAS  PubMed  Google Scholar 

  22. Berg CM, Lissner L, Aires N, et al. Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA. Eur J Cardiovasc Prev Rehabil. 2005;12:115–125. doi: 10.1097/00149831-200504000-00005.

    Article  PubMed  Google Scholar 

  23. Rose GA, Blackburn H. Cardiovascular Survey Methods. Geneva: World Health Organization; 1968.

    Google Scholar 

  24. Plotkin JS, Scott VL, Pinna A, et al. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg. 1996;2:426–430.doi: 10.1002/lt.500020604.

    Article  CAS  PubMed  Google Scholar 

  25. Agarwal DP. Cardioprotective effects of light–moderate consumption of alcohol: a review of putative mechanisms. Alcohol Alcohol. 2002;37:409–415. doi: 10.1093/alcalc/37.5.409.

    CAS  PubMed  Google Scholar 

  26. Malyutina S, Bobak M, Kurilovitch S, et al. Relation between heavy and binge drinking and all-cause and cardiovascular mortality in Novosibirsk, Russia: a prospective cohort study. Lancet. 2002;360:1448–1454. doi: 10.1016/S0140-6736(02)11470-X.

    Article  PubMed  Google Scholar 

  27. Murray RP, Connett JE, Tyas SL, et al. Alcohol volume, drinking pattern, and cardiovascular disease morbidity and mortality: is there a U-shaped function? Am J Epidemiol. 2002;155:242–248. doi: 10.1093/aje/155.3.242.

    Article  PubMed  Google Scholar 

  28. Makelä P, Paljärvi T, Poikolainen K. Heavy and nonheavy drinking occasions, all-cause and cardiovascular mortality and hospitalizations: a follow-up study in a population with a low consumption level. J Stud Alcohol. 2005;66:722–728.

    PubMed  Google Scholar 

  29. Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med. 2000;133:592–599.

    CAS  PubMed  Google Scholar 

  30. Antonelli A, Ferri C, Fallahi P, et al. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care. 2005;28:2548–2550. doi: 10.2337/diacare.28.10.2548.

    Article  PubMed  Google Scholar 

  31. Ishizaka N, Ishizaka Y, Takahashi E, et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet. 2002;359:133–135. doi: 10.1016/S0140-6736(02)07339-7.

    Article  PubMed  Google Scholar 

  32. Ishizaka N, Ishizaka Y, Takahashi E, et al. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation. 2002;105:1028–1030. doi: 10.1161/hc0902.105718.

    Article  PubMed  Google Scholar 

  33. Bilora F, Rinaldi R, Boccioletti V, et al. Chronic viral hepatitis: a prospective factor against atherosclerosis. A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aorta. Gastroenterol Clin Biol. 2002;26:1001–1004.

    CAS  PubMed  Google Scholar 

  34. Völzke H, Schwahn C, Wolff B, et al. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis. 2004;174:99–103. doi: 10.1016/j.atherosclerosis.2004.01.010.

    Article  PubMed  Google Scholar 

  35. Holstein A, Hinze S, Thiessen E, et al. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol. 2002;17:677–681. doi: 10.1046/j.1440-1746.2002.02755.x.

    Article  PubMed  Google Scholar 

  36. Tamura M, Kihara Y, Otsuki M. Carotid intima-media thickness in patients with liver cirrhosis associated with diabetes mellitus. Diabetes Res Clin Pract. 2007;78:176–181. doi: 10.1016/j.diabres.2007.03.013.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, 413 45, Gothenburg, Sweden

    Evangelos Kalaitzakis, Annika Rosengren, Tomas Skommevik & Einar Björnsson

Authors
  1. Evangelos Kalaitzakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Annika Rosengren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomas Skommevik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Einar Björnsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Evangelos Kalaitzakis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalaitzakis, E., Rosengren, A., Skommevik, T. et al. Coronary Artery Disease in Patients with Liver Cirrhosis. Dig Dis Sci 55, 467–475 (2010). https://doi.org/10.1007/s10620-009-0738-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-009-0738-z

Keywords

Search

Navigation